2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
Published: noviembre 13, 2016
- Peripheral Artery Disease (PAD) of the lower extremities involves arteries in the legs that are blocked by atherosclerosis. PAD is a serious medical condition affecting 8.5 million Americans by age 40, and over 200 million people worldwide.
- Risk factors for PAD include older age, diabetes, smoking, high cholesterol, high blood pressure and family history of PAD.
- Early diagnosis by healthcare providers facilitates early treatment that improves blood flow to the legs including exercise, medical drug therapy and revascularization.
New PAD Guidelines Released at Scientific Sessions 2016
Mark Creager, MD, immediate past president of the American Heart | American Stroke Association announces the publication of the 2016 Peripheral Artery Disease Guidelines and highlights PAD programming at Scientific Sessions 2016 in New Orleans intended to inform practitioners about the new recommendations for optimizing patient care and outcomes.
Supporting Materials
- Commentary: Advancing Our Knowledge in Atherosclerotic Peripheral Vascular Disease by Mark A. Creager, MD, FAHA1 and Katherine Sheehan, PhD2
- Top Things to Know: : Top Things to Know
- 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary
- Slide Set (PPT)
- Video: New PAD Guidelines Released at Scientific Sessions 2016
- AHA News: Treatment guidelines: PAD patients should take statins, blood thinners
- News Release: New peripheral artery disease guidelines emphasize medical therapy and structured exercise
Recommended Reading
- Sedentary Behavior and Cardiovascular Morbidity and Mortality: A Science Advisory From the American Heart Association
- Measurement and Interpretation of the Ankle-Brachial Index: A Scientific Statement From the American Heart Association
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update